Clinical Trials

NCT06253520 | ACTIVE_NOT_RECRUITING | PHASE1
210 participants

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-08
Start Date:
2024-05-16
Completion:
2029-02-20
Conditions
  • Metastatic Solid Cancers
  • Colorectal Cancer
  • Breast Cancer
  • Non-Small Cell Lung Cancer
  • Gastrointestinal Cancer
  • Ovarian Cancer
  • Genitourinary Cancer
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT06251310 | RECRUITING | PHASE1
186 participants

SW-682 in Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-08
Start Date:
2024-07-30
Completion:
2030-01-31
Conditions
  • Advanced Solid Tumor
  • Mesothelioma, Malignant
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page